Literature DB >> 12457909

Levels of mature cross-links and advanced glycation end product cross-links in human vitreous.

Yukihiro Matsumoto1, Masaaki Takahashi, Makoto Chikuda, Kiyomi Arai.   

Abstract

PURPOSE: To determine the levels of pyridinoline and deoxypyridinoline, two mature enzymatic cross-links, and pentosidine, an advanced glycation end product (AGE) cross-link, in the human vitreous, and to investigate the correlations among the cross-links and the effects of aging and diabetes mellitus (DM) on the levels of cross-links.
METHODS: Forty-five vitreous samples were collected from 32 patients (32 eyes) undergoing vitrectomy for diabetic retinopathy (DM group) and from 13 patients (13 eyes) (control group) who were age- and sex-matched patients with idiopathic macular hole or epiretinal membrane with no systemic conditions. The levels of the cross-links were determined using high-performance liquid chromatography after acid hydrolysis and pretreatment with SP-Sephadex.
RESULTS: The levels of pentosidine, pyridinoline, and deoxypyridinoline were 27.3 +/- 23.1 (mean +/- SD) pmol/mL (detectable in 45 of 45 specimens), 79.0 +/- 40.2 ng/mL (43 of 45 specimens), and 54.0 +/- 9.5 (32 of 45 specimens) ng/mL, respectively. When the vitreous samples from the DM and the control groups were compared, a significant difference (P <.05) was found in the pentosidine level but not in the levels of pyridinoline or deoxypyridinoline. No significant correlations were found between age and the cross-links. Significant correlations (P <.01) were found among the cross-links.
CONCLUSIONS: The results indicate that mature cross-link substances exist in the human vitreous. The results also suggest that glycation may occur in the vitreous after mature cross-links form and result in the formation of AGE cross-links. In human vitreous from patients with DM, increased levels of AGE cross-links may stabilize the formation of mature cross-links, but they did not increase the mature cross-links.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12457909     DOI: 10.1016/s0021-5155(02)00537-3

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  3 in total

1.  Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment.

Authors:  Carmela Capeans Tomé; María Victoria De Rojas Silva; Javier Rodríguez-García; Santiago Rodríguez-Segade; M Sánchez-Salorio
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-06-10       Impact factor: 3.117

2.  Relationship between Pentosidine and Pyridinoline Levels in Human Diabetic Cataract Lenses.

Authors:  Hirotaka Hashimoto; Kiyomi Arai; Makoto Chikuda; Yoshitaka Obara
Journal:  J Clin Biochem Nutr       Date:  2010-09-29       Impact factor: 3.114

3.  Vitreous advanced glycation endproducts and α-dicarbonyls in retinal detachment patients with type 2 diabetes mellitus and non-diabetic controls.

Authors:  Bernardina T Fokkens; Douwe J Mulder; Casper G Schalkwijk; Jean L Scheijen; Andries J Smit; Leonoor I Los
Journal:  PLoS One       Date:  2017-03-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.